Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education) Peking University Cancer Hospital&Institute Beijing 100142 China;
Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education) Peking University Cancer Hospital&Institute Beijing 100142 China;
Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education) Peking University Cancer Hospital&Institute Beijing 100142 China;
Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education) Peking University Cancer Hospital&Institute Beijing 100142 China;
Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education) Peking University Cancer Hospital&Institute Beijing 100142 China;
Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education) Peking University Cancer Hospital&Institute Beijing 100142 China;
Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education) Peking University Cancer Hospital&Institute Beijing 100142 China;
Immunotherapy; Hypomethylating agent; Classical Hodgkin lymphoma; Survival; Case report;